Low-Dose Cariprazine for MDD Tied to Anxiety Reduction

(MedPage Today) -- NEW ORLEANS -- Low-dose cariprazine (Vraylar) was associated with reductions in anxiety for patients with major depressive disorder (MDD), and the potential adjunctive therapy for this population also demonstrated improvements...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news